Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas

NCT02175745 is registered in ClinicalTrials.gov with Erik Mittra as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas
Lead sponsor
Erik Mittra
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2014
Completion date
December 31, 2015
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult anaplastic ependymoma, adult anaplastic oligodendroglioma, adult brain stem glioma, adult diffuse astrocytoma, adult giant cell glioblastoma, adult glioblastoma, adult gliosarcoma, adult mixed glioma, adult oligodendroglioma, adult pilocytic astrocytoma, adult pineal gland astrocytoma, adult subependymal giant cell astrocytoma, childhood high-grade cerebellar astrocytoma, childhood high-grade cerebral astrocytoma, childhood low-grade cerebellar astrocytoma, childhood low-grade cerebral astrocytoma, recurrent adult brain tumor, recurrent childhood anaplastic astrocytoma, recurrent childhood anaplastic oligoastrocytoma, recurrent childhood anaplastic oligodendroglioma, recurrent childhood brain stem glioma, recurrent childhood cerebellar astrocytoma, recurrent childhood cerebral astrocytoma, recurrent childhood diffuse astrocytoma, recurrent childhood fibrillary astrocytoma, recurrent childhood gemistocytic astrocytoma, recurrent childhood giant cell glioblastoma, recurrent childhood glioblastoma, recurrent childhood gliomatosis cerebri, recurrent childhood gliosarcoma, recurrent childhood oligoastrocytoma, recurrent childhood oligodendroglioma, recurrent childhood pilomyxoid astrocytoma, recurrent childhood protoplasmic astrocytoma, recurrent childhood subependymal giant cell astrocytoma, recurrent childhood visual pathway and hypothalamic glioma, recurrent childhood visual pathway glioma, untreated childhood anaplastic astrocytoma, untreated childhood anaplastic oligoastrocytoma, untreated childhood anaplastic oligodendroglioma, untreated childhood brain stem glioma, untreated childhood cerebellar astrocytoma, untreated childhood cerebral astrocytoma, untreated childhood diffuse astrocytoma, untreated childhood fibrillary astrocytoma, untreated childhood gemistocytic astrocytoma, untreated childhood giant cell glioblastoma, untreated childhood glioblastoma, untreated childhood gliomatosis cerebri, untreated childhood gliosarcoma, untreated childhood oligoastrocytoma, untreated childhood oligodendroglioma, untreated childhood pilomyxoid astrocytoma, untreated childhood protoplasmic astrocytoma, untreated childhood subependymal giant cell astrocytoma, untreated childhood visual pathway and hypothalamic glioma, untreated childhood visual pathway glioma